Eli Lilly LLY Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 83%+1.7pp | 81.3%+2.1pp | 79.2%+2.5pp | 76.8%+2.6pp | |
| Net margin | 31.7%+8.2pp | 23.5%+8.2pp | 15.4%-6.5pp | 21.9%+2.2pp | |
| EBITDA margin | 42.5%+10.5pp | 32.1%+8.4pp | 23.7%-5.5pp | 29.2%+2.0pp | |
| Free cash flow margin | 13.8%+5.4pp | 8.3%— | —— | 20.1%-1.3pp | |
| Returns | |||||
| Return on equity | 101.2%+16.6pp | 84.6%+35.6pp | 48.9%-14.7pp | 63.6%-12.7pp | |
| Return on assets | 21.6%+6.8pp | 14.8%+5.6pp | 9.2%-3.5pp | 12.7%+1.0pp | |
| Return on invested capital | 38.3%+11.8pp | 26.4%+8.9pp | 17.5%-8.4pp | 25.9%-0.7pp | |
| Efficiency | |||||
| Asset turnover | 0.7×+0.1× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Inventory turnover | 1×-0.2× | 1.3×-0.1× | 1.4×-0.2× | 1.6×-0.2× | |
| Liquidity | |||||
| Current ratio | 1.6×+0.4× | 1.2×+0.2× | 0.9×-0.1× | 1.1×-0.2× | |
| Quick ratio | 1.2×+0.3× | 0.9×+0.2× | 0.7×-0.1× | 0.8×-0.2× | |
| Cash ratio | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | |
| Leverage | |||||
| Debt-to-equity | 1.6×-0.8× | 2.4×0.0× | 2.4×+0.9× | 1.6×-0.4× | |
| Debt-to-assets | 0.4×-0.1× | 0.4×0.0× | 0.4×+0.1× | 0.3×0.0× | |
| Net debt / EBITDA | 1.3×-0.9× | 2.2×-0.7× | 2.9×+1.1× | 1.8×0.0× | |
| Per Share | |||||
| Book value per share | $29.51+86.9% | $15.79+32.4% | $11.93+1.3% | $11.77+19.5% | |
| Valuation | |||||
| Market capitalization | $961.86B+38.5% | $694.27B+25.5% | $553.41B+59.2% | $347.61B+31.6% | |
| Enterprise value | $997.32B+37.4% | $725.79B+25.8% | $576.93B+59.1% | $362.51B+30.4% | |
| Price / earnings | 46.6×-19.0× | 65.6×-40.1× | 105.6×+49.9× | 55.7×+8.3× | |
| Price / sales | 14.8×-0.7× | 15.4×-0.8× | 16.2×+4.0× | 12.2×+2.8× | |
| Price / book | 36.2×-12.4× | 48.6×-2.7× | 51.4×+18.7× | 32.6×+3.2× | |
| EV / EBITDA | 36×-14.3× | 50.2×-21.2× | 71.4×+27.9× | 43.5×+7.4× | |
| EV / sales | 15.3×-0.8× | 16.1×-0.8× | 16.9×+4.2× | 12.7×+2.9× | |
| Free cash flow yield | 0.9%+0.4pp | 0.5%— | —— | 1.6%-0.6pp | |
| Earnings yield | 2.1%+0.6pp | 1.5%+0.6pp | 0.9%-0.8pp | 1.8%-0.3pp | |
| Dividend yield | 0.6%-0.1pp | 0.7%-0.1pp | 0.7%-0.3pp | 1%-0.2pp | |
| PEG ratio | 0.5×-0.2× | 0.6×— | —— | 4.7×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Eli Lilly's ratios come from?
- Every ratio is computed from Eli Lilly's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
